ALNYLAM PHARMACEUT

The current price of DUL is 135.683 CHF — it has decreased by 18.79% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ALNYLAM PHARMACEUT stocks are traded under the ticker DUL.

ALNYLAM PHARMACEUT is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.

DUL stock is 23.13% volatile and has beta coefficient of 1.35. Check out the list of the most volatile stocks — is ALNYLAM PHARMACEUT there?

One year price forecast for ALNYLAM PHARMACEUT has a max estimate of 360.533 CHF and a min estimate of 124.133 CHF.

DUL earnings for the last quarter are 1.05 CHF per share, whereas the estimation was −1.32 CHF resulting in a 179.55% surprise. The estimated earnings for the next quarter are −1.00 CHF per share. See more details about ALNYLAM PHARMACEUT earnings.

ALNYLAM PHARMACEUT revenue for the last quarter amounts to ‪687.11 M‬ CHF despite the estimated figure of ‪363.23 M‬ CHF. In the next quarter revenue is expected to reach ‪367.86 M‬ CHF.

Yes, you can track ALNYLAM PHARMACEUT financials in yearly and quarterly reports right on TradingView.

DUL net income for the last quarter is ‪−116.08 M‬ CHF, while the quarter before that showed ‪135.27 M‬ CHF of net income which accounts for −185.81% change. Track more ALNYLAM PHARMACEUT financial stats to get the full picture.

Today ALNYLAM PHARMACEUT has the market capitalization of ‪16.75 B‬, it has increased by 3.05% over the last week.

No, DUL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, DUL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALNYLAM PHARMACEUT stock right from TradingView charts — choose your broker and connect to your account.

DUL reached its all-time high on Sep 26, 2022 with the price of 200.858 CHF, and its all-time low was 147.898 CHF and was reached on Mar 14, 2022.
See other stocks reaching their highest and lowest prices.

As of Apr 20, 2024, the company has ‪2.10 K‬ employees. See our rating of the largest employees — is ALNYLAM PHARMACEUT on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALNYLAM PHARMACEUT technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALNYLAM PHARMACEUT stock shows the strong sell signal. See more of ALNYLAM PHARMACEUT technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on ALNYLAM PHARMACEUT future price: according to them, DUL price has a max estimate of 360.53 CHF and a min estimate of 124.13 CHF. Read a more detailed ALNYLAM PHARMACEUT forecast: see what analysts think of ALNYLAM PHARMACEUT and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALNYLAM PHARMACEUT EBITDA is ‪−192.06 M‬ CHF, and current EBITDA margin is −12.48%. See more stats in ALNYLAM PHARMACEUT financial statements.